Publications by the researcher in collaboration with Juan José Ríos Blanco (15)

2024

  1. Recommendations for the diagnosis and treatment of anti-neutrophil cytoplasmic autoantibody associated vasculitis

    Nefrologia

2023

  1. Nailfold videocapillaroscopy patterns in systemic sclerosis: implications for cutaneous subsets, disease features and prognostic value for survival

    Clinical and experimental rheumatology, Vol. 41, Núm. 8, pp. 1695-1703

2022

  1. Anti–Polymyositis/Scl Antibodies in Systemic Sclerosis Clinical Associations in a Multicentric Spanish Cohort and Review of the Literature

    Journal of Clinical Rheumatology, Vol. 28, Núm. 1, pp. E180-E188

2021

  1. Corrigendum to ‘Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation’ [AUTREV 19-5 (2020) 102507] (Autoimmunity Reviews (2020) 19(5), (S1568997220300598), (10.1016/j.autrev.2020.102507))

    Autoimmunity Reviews

2020

  1. Comparison of the Birmingham Vasculitis Activity Score and the Five-Factor Score to Assess Survival in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis: A Study of 550 Patients From Spain (REVAS Registry)

    Arthritis Care and Research, Vol. 72, Núm. 7, pp. 1001-1010

  2. Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation

    Autoimmunity Reviews, Vol. 19, Núm. 5

2018

  1. Correction to: First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study (Clinical Rheumatology, (2018), 37, 4, (999-1009), 10.1007/s10067-017-3936-7)

    Clinical Rheumatology

  2. First clinical symptom as a prognostic factor in systemic sclerosis: results of a retrospective nationwide cohort study

    Clinical Rheumatology, Vol. 37, Núm. 4, pp. 999-1009

  3. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group

    Rheumatology International, Vol. 38, Núm. 3, pp. 363-374

2017

  1. Changes in the pattern of death of 987 patients with systemic sclerosis from 1990 to 2009 from the nationwide Spanish Scleroderma Registry (RESCLE)

    Clinical and Experimental Rheumatology, Vol. 35, pp. S40-S47

  2. Clinical and epidemiological differences between men and women with systemic sclerosis: A study in a Spanish systemic sclerosis cohort and literature review

    Clinical and Experimental Rheumatology, Vol. 35, pp. S89-S97

  3. Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis

    Clinical and Experimental Rheumatology, Vol. 35, pp. S98-S105

  4. Very early and early systemic sclerosis in the Spanish scleroderma Registry (RESCLE) cohort

    Autoimmunity Reviews, Vol. 16, Núm. 8, pp. 796-802

2016

  1. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry

    Seminars in Arthritis and Rheumatism, Vol. 46, Núm. 2, pp. 200-208

2014

  1. Early-Versus late-Onset systemic sclerosis: Differences in clinical presentation and outcome in 1037 patients

    Medicine (United States), Vol. 93, Núm. 2, pp. 73-81